Rocket Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $527.7M
Liabilities Breakdown FY2024
Total Liabilities: $64.5M
Asset Breakdown
Total Assets: $527.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $163.6M | 31.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $36.8M | 7.0% |
| Goodwill | $39.2M | 7.4% |
| Intangible Assets | $25.2M | 4.8% |
| Other Assets | $263.0M | 49.8% |
Liabilities Breakdown
Total Liabilities: $64.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $64.5M | 100.0% |